HHTM

By Dr. Jennifer J. Gans People with bothersome tinnitus are particularly vulnerable to misinformation. This is not because they are gullible. It is because tinnitus can be frightening, unfamiliar, and difficult to understand—especially when it first appears. When someone suddenly hears a sound that no one else can hear, the natural response is often to search for an explanation. Why

ATLANTA, GEORGIA — Aware Defense has been awarded a five-year, sole-source Program of Record contract by the U.S. Navy’s Naval Air Systems Command (NAVAIR) Aircrew Systems Program Office (PMA-202) to provide custom hearing protection for Naval Aviation personnel. The program will use Aware’s eFit 3D ear scanning technology to capture individual ear canal geometry and manufacture custom hearing protection and

The British Irish Hearing Instrument Manufacturers Association (BIHIMA) is launching a national awareness campaign aimed at helping people recognize potential signs of hearing loss and encouraging earlier conversations about hearing care. Launching September 14, the Hearing Loss Red Flags campaign focuses on everyday behaviors that may indicate an emerging hearing difficulty, such as increasing the television volume, frequently asking others

Pediatric cochlear implant candidacy has expanded significantly in recent years, creating opportunities for earlier intervention and opening the door to implantation for children who may not have been considered candidates in the past. Dr. Bob Traynor is joined by Dr. Samantha Scharf, Research Assistant Professor in the Department of Otolaryngology/Head and Neck Surgery at the University of North Carolina at

A large real-world study of cochlear implant users has found generally high levels of satisfaction with external audio processors, while also identifying a strong association between satisfaction and how long people use their devices each day. Published September 7 in Frontiers in Psychology, the study analyzed responses from 861 cochlear implant users in Germany and the United Kingdom. Researchers examined

MILAN, ITALY — Amplifon has been named to TIME magazine’s World’s Best Companies of 2026 list, marking the fourth consecutive year the hearing care company has been included in the global ranking. The annual list, developed by TIME in collaboration with Statista, evaluates companies across three primary areas: employee satisfaction, economic performance, and transparency around sustainability. The 2026 ranking includes

For people with hearing loss, many of the biggest challenges happen outside the clinic—from navigating difficult listening situations to managing the emotional and social impact of hearing loss. Shari Eberts is joined by Dan Reiner, Director of Communications and Marketing at the Hearing Loss Association of America (HLAA), to explore how the organization can complement clinical hearing care and help

STÄFA, SWITZERLAND — Sonova has acquired Høreservice Danmark, a rapidly growing Danish hearing care provider built around a fully mobile model that brings hearing testing, counseling, and hearing aid services directly to patients in their homes. Danish corporate records show that Sonova AG became the 100% owner of Høreservice Danmark effective September 1, 2026. Jan Peter Rekling was also appointed

LONDON, UK — TinniSoothe is expanding its partnership with Boots Hearingcare, bringing its wearable tinnitus sound therapy device into select Boots World of Hearing stores across the UK. The move expands on a partnership launched in 2025, when TinniSoothe became available through the Boots Hearingcare online store. Beginning this month, customers will also be able to explore the device in

MONTPELLIER, FRANCE — Sensorion has received authorization from France’s National Agency for Medicines and Health Products Safety (ANSM) to begin a Phase I/II clinical trial of SENS-601, its investigational gene therapy targeting GJB2-related hearing loss. The authorization, granted August 31 through ANSM’s Fast Track assessment process, clears the company to initiate the HearConnex clinical trial in France. Site start-up activities